Your browser doesn't support javascript.
Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants.
Hu, Chao; Shen, Meiying; Han, Xiaojian; Chen, Qian; Li, Luo; Chen, Siyin; Zhang, Jing; Gao, Fengxia; Wang, Wang; Wang, Yingming; Li, Tingting; Li, Shenglong; Huang, Jingjing; Wang, Jianwei; Zhu, Ju; Chen, Dan; Wu, Qingchen; Tao, Kun; Pang, Da; Jin, Aishun.
  • Hu C; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Shen M; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Han X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, PR China.
  • Chen Q; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Li L; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Chen S; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Zhang J; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Gao F; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Wang W; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Wang Y; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Li T; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Li S; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Huang J; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Wang J; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Zhu J; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Chen D; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Wu Q; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Tao K; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Pang D; Chongqing Key Laboratory of Cancer Immunology Translational Medicine, Chongqing Medical University, Chongqing 400016, PR China.
  • Jin A; Department of Immunology, College of Basic Medicine, Chongqing Medical University, Chongqing 400016, PR China.
Genes Dis ; 9(1): 216-229, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1293799
ABSTRACT
Despite the growing knowledge of T cell responses in COVID-19 patients, there is a lack of detailed characterizations for T cell-antigen interactions and T cell functions. Here, with a predicted peptide library from SARS-CoV-2 S and N proteins, we found that specific CD8+ T cell responses were identified in over 75% of COVID-19 convalescent patients (15/20) and an epitope from the N protein, N361-369 (KTFPPTEPK), was the most dominant epitope from our selected peptide library. Importantly, we discovered 2 N361-369-specific T cell receptors (TCRs) with high functional avidity that were independent of the CD8 co-receptor. These TCRs exhibited complementary cross-reactivity to several presently reported N361-369 mutant variants, as to the wild-type epitope. Further, the natural functions of these TCRs in the cytotoxic immunity against SARS-CoV-2 were determined with dendritic cells (DCs) and the lung organoid model. We found that the N361-369 epitope could be normally processed and endogenously presented by these different types of antigen presenting cells, to elicit successful activation and effective cytotoxicity of CD8+ T cells ex vivo. Our study evidenced potential mechanisms of cellular immunity to SARS-CoV-2, and illuminated potential ways of viral clearance in COVID-19 patients. These results indicate that utilizing CD8-independent TCRs against SARS-CoV-2-associated antigens may provide functional superiority that is beneficial for the adoptive cell immunotherapies based on natural or genetically engineered T cells. Additionally, this information is highly relevant for the development of the next-generation vaccines with protections against continuously emerged SARS-CoV-2 mutant strains.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Language: English Journal: Genes Dis Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Language: English Journal: Genes Dis Year: 2022 Document Type: Article